Inoviv Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Inoviv is a small biotechnology research company based in London, England, that uses targeted proteomics to support pharmaceutical partners in biomarker test development. The business focuses on enabling precise measurement of protein biomarkers to inform the design and validation of biomarker workflows for drug research. By providing end-to-end biomarker measurement services, the company aims to deliver quantitative data that underpins biomarker decisions in development programs. Its customers are pharmaceutical companies seeking reliable biomarker tests and measurement pipelines for research use. The work addresses the need for accurate, fully quantitative biomarker readouts in biological samples, including low-level markers in plasma. In early March 2024, Inoviv announced the NeuroKey-3 assay, an end-to-end service to quantify key neurodegeneration markers in human plasma, reflecting an expansion of its offerings.